Subcutaneous Treatment vs. IV Infusion for HER2-Positive Breast Cancer Holt, Chuck Holt, Chuck Less Oncology Times. 42(10):1,12-13, May 20, 2020. Favorites PDF Get Content & Permissions Free
Safety & Efficacy of Trifluridine/Tipiracil in Metastatic Gastric Cancer George, Ben George, Ben Less Oncology Times. 42(10):1,10-11, May 20, 2020. Favorites PDF Get Content & Permissions Free
Repurposing Classic Chemotherapy Drug to Overcome Therapy Resistance Less Oncology Times. 42(10):1,15, May 20, 2020. Favorites PDF Get Content & Permissions Free
Pemigatinib (Pemazyre®) Mann, Janelle E Mann, Janelle E Less Oncology Times. 42(10):14, May 20, 2020. Favorites PDF Get Content & Permissions Free
Immunotherapy Effectiveness in Metastatic Prostate Cancer Subset Froelich, Warren Froelich, Warren Less Oncology Times. 42(10):17, May 20, 2020. Favorites PDF Get Content & Permissions Free
Opioid Prescribing Guidelines for Pain Management in Cancer Das, Dibash Kumar Das, Dibash Kumar Less Oncology Times. 42(10):18,21, May 20, 2020. Favorites PDF Get Content & Permissions Free
Rare, Aggressive Thyroid Cancers Growing in Incidence Conick, Hal Conick, Hal Less Oncology Times. 42(10):19, May 20, 2020. Favorites PDF Get Content & Permissions Free
COVID-19: What Cancer Patients & Survivors Need to Know Eastman, Peggy Eastman, Peggy Less Oncology Times. 42(10):20-21, May 20, 2020. Favorites PDF Get Content & Permissions Free
COVID-19 Symptom Tracker Keeps Cancer Patients Connected Wilson, Rebecca Wilson, Rebecca Less Oncology Times. 42(10):26, May 20, 2020. Favorites PDF Get Content & Permissions Free
Oncology's Telehealth Growth in the COVID-19 Pandemic DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 42(10):27,30-31, May 20, 2020. Favorites PDF Get Content & Permissions Free
Small Study Finds Remdesivir Benefit in COVID-19 But Questions Remain Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 42(10):28-29, May 20, 2020. Favorites PDF Get Content & Permissions Free
FDA Updates Highlighting the Latest Cancer Treatments Less Oncology Times. 42(10):32-38, May 20, 2020. Favorites PDF Get Content & Permissions Free
UpToDate® Less Oncology Times. 42(10):16, May 20, 2020. Favorites PDF Get Content & Permissions Free
3 QUESTIONS ON... Why Addressing Hearing Loss in Survivors of Childhood Cancers Matters: With Emily S. Tonorezos, MD, of the Adult Long-Term Follow-Up Program at Memorial Sloan Kettering Cancer Center DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 42(10):42, May 20, 2020. Favorites PDF Get Content & Permissions Free
Shop Talk Less Oncology Times. 42(10):39-41, May 20, 2020. Favorites PDF Get Content & Permissions Free
